Costs of implementing long-acting injectable cabotegravir as HIV prophylaxis in Brazil
Article by ImPrEP published at Physis in2023, September https://doi.org/10.1590/S0103-7331202333021
Article by ImPrEP published at Physis in2023, September https://doi.org/10.1590/S0103-7331202333021
Article by ImPrEP published at Therapeutic Advances in Infectious Disease in 2023, February https://doi.org/10.1177/20499361231153548
Article by ImPrEP published at JMIR Public Health and Surveillance in 2023, April http://dx.doi.org/10.2196/44961
Article by ImPrEP published at The Lancet HIV in 2022, December https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(22)00331-9/fulltext
Article by ImPrEP published at BMC Health in 2022, April https://link.springer.com/article/10.1186/s12913-022-07900-y
Article by ImPrEP published at Cadernos de Saúde Pública in 2022, January http://dx.doi.org/10.1590/0102-311X00290620
Article by ImPrEP published at International Journal of Environmental Research and Public Health in 2022, February https://www.mdpi.com/1660-4601/19/3/1704/html
Article by ImPrEP published at Plos Global Public Health in 2022, July https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0000678
Article by ImPrEP published at AIDS and Behavior in 2022, September https://link.springer.com/article/10.1007/s10461-022-03836-w
Article by ImPrEP published in Journal of International AIDS Society in 2022, October https://onlinelibrary.wiley.com/doi/10.1002/jia2.25974
